Nathan Dowden

Nathan Dowden

President at ENTRADA THERAPEUTICS, INC.

Net worth: 2 M $ as of 29/04/2024

54 year
Commercial Services
Consumer Services
Process Industries

Profile

Nathan J.
Dowden
is currently the President & Chief Operating Officer at Entrada Therapeutics, Inc. He previously worked as a Managing Director at Huron Consulting Group, Inc. from 2014 to 2016.
He also held the position of Managing Director at Frankel Group LLC.
Prior to that, he worked as a Senior Consultant at Ernst & Young LLP and as a Principal at G.D.
Searle & Co., Inc. From 2013 to 2019, he worked as an Analyst at CIGNA HealthCare, Inc. He also served as the Senior VP-Strategy & Corporate Development at Rubius Therapeutics, Inc. from 2016 to 2019.
Mr. Dowden completed his undergraduate degree at the University of Connecticut and holds an MBA from The University of Chicago Booth School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/03/2024 137,204 ( 0.41% ) 2 M $ 29/04/2024

Nathan Dowden active positions

Former positions of Nathan Dowden

CompaniesPositionEnd
RUBIUS THERAPEUTICS Corporate Officer/Principal 24/07/2019
Corporate Officer/Principal 31/12/2018
HURON CONSULTING GROUP INC. Corporate Officer/Principal 29/02/2016
Corporate Officer/Principal -
See the detail of Nathan Dowden's experience

Training of Nathan Dowden

University of Connecticut Undergraduate Degree
The University of Chicago Booth School of Business Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Nathan Dowden's experience

Connections

57

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
HURON CONSULTING GROUP INC.

Commercial Services

Private companies5

Commercial Services

Process Industries

Health Services

Health Technology

Entrada Therapeutics, Inc.

See company connections